Author Reply: Re-Evaluating the Impact of KRAS Mutations in Stage III Nonsquamous NSCLC Treated With Chemoradiation and Immunotherapy

Nikhil P. Mankuzhy, Valentina Santo, Biagio Ricciuti, Narek Shaverdian

Open source

DOI
10.1016/j.jtho.2026.103979
Published
2026-09
Container
Journal of Thoracic Oncology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jtho.2026.103979,
  title = {Author Reply: Re-Evaluating the Impact of KRAS Mutations in Stage III Nonsquamous NSCLC Treated With Chemoradiation and Immunotherapy},
  author = {Nikhil P. Mankuzhy and Valentina Santo and Biagio Ricciuti and Narek Shaverdian},
  year = {2026},
  journal = {Journal of Thoracic Oncology},
  doi = {10.1016/j.jtho.2026.103979},
  url = {https://doi.org/10.1016/j.jtho.2026.103979}
}

RIS

TY  - JOUR
TI  - Author Reply: Re-Evaluating the Impact of KRAS Mutations in Stage III Nonsquamous NSCLC Treated With Chemoradiation and Immunotherapy
AU  - Nikhil P. Mankuzhy
AU  - Valentina Santo
AU  - Biagio Ricciuti
AU  - Narek Shaverdian
PY  - 2026
JO  - Journal of Thoracic Oncology
DO  - 10.1016/j.jtho.2026.103979
UR  - https://doi.org/10.1016/j.jtho.2026.103979
ER  - 

APA

Mankuzhy, N. P., Santo, V., Ricciuti, B., & Shaverdian, N. (2026). Author Reply: Re-Evaluating the Impact of KRAS Mutations in Stage III Nonsquamous NSCLC Treated With Chemoradiation and Immunotherapy. Journal of Thoracic Oncology. https://doi.org/10.1016/j.jtho.2026.103979

Source records